Rationale Cocaine-induced changes in D 2 receptors have been implicated in the expression of sensitized behavioral responses and addiction-like behaviors; however, the influence of D 3 receptors is less clear. Objectives To characterize the effects of repeated cocaine administration on the sensitivity of rats to D 2 -and D 3 -mediated behaviors, as well as the binding properties of ventral striatal D 2 -like and D 3 receptors. Methods Pramipexole was used to assess the sensitivity of rats to D 3 /D 2 agonist-induced yawning, hypothermia, and locomotor activity, 24 h, 72 h, 10, 21, and 42 days after repeated cocaine or saline administration. The locomotor effects of cocaine (42 day) and the binding properties of ventral striatal D 2 -like and D 3 receptors (24 h and 42 days) were also evaluated.
Introduction
Early studies on the effects of repeated cocaine administration described a common behavioral sequelae in monkeys, dogs, and rats in which the behavioral and physiologic effects of cocaine were observed sooner, and with greater intensity following repeated, intermittent cocaine administration (Downs and Eddy 1932a, b; Post and Rose 1976; Tatum and Seevers 1929) , and the progressive and persistent nature of these effects, frequently referred to as behavioral sensitization, are now well established in rodents. Although some important differences exist between effects of experimenter-and self-administered cocaine (Jacobs et al. 2003) , a variety of progressive and time-dependent neuropharmacologic and behavioral changes have been shown to correspond to the expression of the sensitized locomotor response to cocaine, including decreases in dopamine transporter (DAT) density and enhancements of cocaine-induced increases in extracellular dopamine, regardless of whether cocaine is experimenter- (Heidbreder et al. 1996; Henry and White 1995; Kalivas and Duffy 1993; Pilotte et al. 1994; Wilson et al. 1994) , or self-administered (Ahmed and Cador 2006; Ferrario et al. 2005; Hooks et al. 1994; Phillips and Di Ciano 1996; Zapata et al. 2003) . The repeated administration of psychostimulants is also known to affect a variety of neurotransmitter systems (e.g., cholinergic, dopaminergic, GABAergic, glutamatergic, opioidergic, and serotonergic), and it is thought that the neuroadaptations that underlie the development and expression of the sensitized behavioral responses are also important for the development of addiction-like behaviors in animals (for reviews, see Kalivas and Stewart 1991; Pierce and Kalivas 1997; Robinson and Berridge 1993; Vanderschuren and Kalivas 2000; Vezina 2004 ). An important theory of the basis of drug addiction posits that drug-induced behavioral sensitization reflects sensitized brain circuits that, in turn, enhance the incentive value of the drugs and the cues associated with them (Robinson and Berridge 1993) . Among the data that support this theory are findings that cocaine-induced sensitization of D 2 -like (D 2 , D 3 , and D 4 ) receptors within the nucleus accumbens plays a role in the increased effectiveness of D 2 -like agonists in inducing cocaine-directed responding (i.e., drug-seeking) following the cessation of cocaine selfadministration (De Vries et al. 2002; Dias et al. 2004; Edwards et al. 2007 ). What is not specified in the theory or demonstrated in these data are the respective roles of the D 2 , D 3 , and D 4 receptors in mediating either the behavioral sensitization or the corresponding neurological changes.
There is, nevertheless, growing evidence to suggest that cocaine, either experimenter-or self-administered, has differential effects on the density/availability/expression of D 2 -like (D 2 , D 3 and D 4 ), with decreases in D 2 receptor levels reported in rodents (Bailey et al. 2008; Conrad et al. 2010; Goeders and Kuhar 1987; Maggos et al. 1998) , and rhesus monkeys (Nader et al. 2006) , and increases in D 3 receptor levels observed in human cocaine overdose fatalities (Segal et al. 1997; Staley and Mash 1996) , and rats with a history of experimenter-(Le Foll et al. 2005) or self-administered cocaine (Conrad et al. 2010; Neisewander et al. 2004 ).
Despite these apparent differences in the effects of cocaine on D 2 and D 3 receptor levels, the lack of agonists or antagonists with high degrees of selectivity for the D 2 or D 3 receptor has made it difficult to parse the relative contributions of these receptor subtypes to the expression of sensitized behavioral responses or addiction-like behaviors. One approach that has been useful in determining the involvement of different dopamine receptor subtypes has been to evaluate the capacity of cocaine to sensitize animals to the selective behavioral effects of D1-like (D 1 and D 5 ) or D 2 -like (D 2 , D 3 , and D 4 ) receptor agonists. Accordingly, increases in SKF-38393-induced tongue protrusions (Neisewander et al. 1996) have been interpreted as a cocaine-induced sensitization of D1-like receptors, whereas enhancements of quinpirole-, or quinelorane-induced sniffing, head movements, or locomotor stimulation (De Vries et al. 2002; Dias et al. 2004; Edwards et al. 2007; Ujike et al. 1990) have been attributed to a sensitization of D 2 receptors. It should be noted, however, that these latter studies do not permit a discrimination between effects produced through the D 2 as opposed to the D 3 receptors as the majority of these effects are observed at doses of quinpirole or quinelorane that are 50-to 250-fold higher than those required to induce behaviors that have been attributed to the selective activation of D 3 receptors, such as yawning (Collins et al. 2007; Collins et al. 2005) , and 5-to 25-fold higher than those required to produce D 2 -mediated effects, such as hypothermia (Chaperon et al. 2003; Collins et al. 2007) .
Support for these sub-type-specific roles of the D 3 and D 2 receptors in the regulation of yawning and hypothermia has been provided by antagonist interaction studies in which D 3 -selective antagonists have been shown to produce dose-dependent and selective rightward shifts of the ascending limb of the dose-response curve for D 2 -like agonist-induced yawning, whereas D 2 -preferring antagonists have been shown to produce selective rightward shifts of the descending limb of the yawning doseresponse curve for D 2 -like agonist-induced yawning at doses that also inhibit the induction of hypothermia (Baladi et al. 2009; Collins et al. 2008; Collins et al. 2007; Collins et al. 2005) . Based on these differential roles of the D 3 (induction) and D 2 (inhibition) receptors in the mediation of yawning, we have hypothesized that cocaine-induced increases in D 3 receptor density and/or sensitivity would result in leftward shifts of the ascending limb of the yawning dose-response curve, whereas decreases in D 2 receptor density would result in rightward shifts of the descending limb of the yawning dose-response curve. Conversely, an increase in the sensitivity of D 2 receptors should result in a leftward shift of the descending limb of the yawning doseresponse curve.
In the current experiments, rats were first given a regimen of once daily cocaine or saline injections prior to assessing the sensitivity of rats to the D 3 -and D 2 -mediated behavioral effects of the D 3 -preferring agonist, pramipexole (and õ30-fold selective for D 3 over D 2 in vivo; Collins et al. 2007 ; õ90-fold selective for D 3 over D 2 in vitro; Millan et al. 2002) . Dose-response curves for pramipexoleinduced yawning, locomotor activity, and hypothermia were obtained 24 h, 72 h, 10, 21, and 42 days after the cessation of cocaine or saline administration to allow for evaluation of the development of cocaine-induced changes in D 3 -and/or D 2 -mediated behavioral effects. To assess the dose-response curves for yawning induced by the indirect cholinergic agonist, physostigmine, and the 5-HT2 receptor agonist, 3-trifluoromethylphenylpiperazin (TFMPP), were also obtained after 24-72 h and 41-43 days of cessation from cocaine or saline administration. In parallel, radioligand binding studies were performed to assess the effects of repeated cocaine administration on the binding properties of ventral striatal D 2 and D 3 receptors 24 h and 42 days after the cessation of cocaine or saline administration.
Methods

Subjects
Male Sprague-Dawley rats (250-300 g) were obtained from Harlan (Indianapolis, IN), and individually housed for the duration of the study in a temperature-(21-23°C), and humidity-controlled environment, on a 12-h dark/light cycle with lights on at 7:00 am. Except during behavioral observations, all animals had free access to standard Purina rodent chow and tap water throughout the course of the experiment. All experimental procedures were approved by the University of Michigan Committee on the Use and Care of Animals and performed in accordance with the Guide for the Care and Use of Laboratory Animals, as adopted and promulgated by the National Institutes of Health.
Sensitization paradigm
In order to establish cocaine-induced behavioral sensitizacage for a period of 7 days according to the following schedule: days 1-2, 15 mg/kg; i.p., and days 3-7, 30 mg/kg; i.p.. Saline-treated rats received once-daily i.p. injections of saline in their home cage. All injections were administered between 1:00 and 1:30 pm. Behavioral observations, locomotor/core body temperature studies, and tissue collection began all 24 h after the last cocaine or saline injection.
Behavioral observations of yawning
Yawning behavior was defined as a prolonged ( 1 s), broad opening of the mouth followed by a rapid closure of the mouth. Prior to experimental sessions, rats were weighed and transferred from their home cage to a clear test chamber (48×23×20 cm, with standard cob bedding and ventilated lid). A mirror was placed behind the test chamber to allow for the simultaneous observation of two individual rats by a trained observer. Rats were allowed a 30-min habituation period prior to the administration of successive doses of saline and test compounds. Dose-response curves for pramipexole-, TFMPP-, and physostigmine-induced yawning were generated using a multiple-dose procedure as previously described (Collins et al. 2008) . Briefly, the total numbers of yawns were counted for the 30-min period immediately following injections of saline followed by five doses of pramipexole (0.01, 0.032, 0.1, 0.32, and 1.0 mg/kg; s.c.), three doses of TFMPP (1.0, 3.2, and 10.0 mg/kg; s.c.), or three doses of physostigmine (0.032, 0.1, and 0.32 mg/kg; i.p.), with successive injections administered at 30-min intervals. Dose-response curves for pramipexole-induced yawning were generated in one group of cocaine-and one group of saline-treated rats (n=8/treatment) tested 24 h, 72 h, 10, 21, and 42 days after the cessation of cocaine/saline injections. Dose-response curves for TFMPP-and physostigmine-induced yawning were generated in a separate group of cocaine-and saline-treated rats (n=8/treatment). Half the rats were exposed to physostigmine, and half were exposed to TFMPP at the 24 h time-point, with the treatments counterbalanced at the 72 h time-point, and again at the 41-and 43-day time-points so that all rats were tested with both physostigmine and TFMPP within 3-day periods corresponding to the short and long periods of cessation. All test sessions were conducted between 12:00 pm and 5:00 pm.
Core body temperature and locomotor activity Core body temperature and locomotor activity were measured using radio-telemetric probes (E-4000 E-Mitter, Mini-Mitter, Bend, OR, USA) implanted in the abdominal cavity of rats. Prior to surgery, rats were anesthetized with ketamine (90 mg/kg, i.p.) and xylazine (15 mg/kg, i.p.), and their abdominal area was shaved and cleaned with alternating applications of betadine and alcohol. A small rostral-caudal incision was made in the abdominal wall to allow for implantation of a radio-telemetric probe. After implantation, the abdominal wall was sutured with absorbable 4-0 chromic gut sutures and the skin was sutured using 5-0 Ethilon® sutures. Rats were allowed a minimum of 7 days to recover prior to the start of the sensitization paradigm. On test day, rats were weighed and returned to ∼ selectivity of cocaine's effects for dopaminergic systems, tion, cocaine was administered once daily in the rat's home their home cages, which were placed on a receiving pad to allow for the real-time collection of locomotor activity and core body temperature with measures taken every minute. At least 45 min of baseline body temperature and locomotor activity were recorded before successive injections of saline and the test compound of interest. Dose-response curves for pramipexole-induced changes in locomotor activity and core body temperature were generated using a multiple-dose procedure as previously described (Collins et al. 2008) . Briefly, injections of saline, 0.01, 0.032, 0.1, 0.32, and 1.0 mg/kg, s.c. pramipexole were separated by 30 min. Dose-response curves for pramipexole-induced changes in locomotor activity and core body temperature were generated in one group of cocaine-and one group of saline-treated (n=6/treatment) rats 24 h, 72 h, 10 and 21 days after the cessation of cocaine/saline injections. Food and water were freely available, and all experiments were conducted between the hours of 11:00 am and 6:00 pm.
In addition, these two groups of cocaine-and salinetreated rats were assessed for the development of a sensitized locomotor response to cocaine at the 42-day time-point. Following a 45-min baseline period, all rats received an i.p. injection of saline followed 60 min later by an i.p. injection of 15 mg/kg cocaine. Saline-and cocaineinduced locomotor activity was collected for 60 min following each injection. D 2 -like and D 3 receptor binding Independent groups of cocaine-and saline-treated (n=10/ treatment) rats were exposed to the regimen of cocaine (or saline) injections and sacrificed by decapitation either 24 h (n= 5/treatment) or 42 days (n =5/treatment) after the cessation of cocaine or saline administration. In order to control for the possible influence of experimental or drug history on the D 3 and D 2 receptor-mediated effects, both the saline-and cocaine-treated rats were exposed to the same experimental procedures that the rats used in the yawning studies were exposed to. Thus, the 24-h groups did not receive any pramipexole injections and were not placed in an observation chamber, whereas the 42-day groups were placed in test chambers at 12:30 pm at the 24 h, 72 h, 10-, and 21-day time-points with injections of saline, 0.01, 0.032, 0.1, 0.32, and 1.0 mg/kg, s.c. pramipexole administered at 30-min intervals. The only difference was that behaviors were not scored. At the specified times, brains were removed and frozen upside down on dry ice prior to being stored at −80°C. Ventral striatum (nucleus accumbens and olfactory tubercle) was isolated by freehand dissection on ice according to a modification of the methods of Glowinski and Iversen (1966) . Dissected brain tissue was homogenized in 20 vol (w/v) of buffer (50 mM Tris; pH 7.4 at 23°C) using a PRO homogenizer (setting 4 for 10 s). The crude homogenate was centrifuged twice (15 min at 48,000×g), and pellets were resuspended each time in 20 vol of buffer. The final pellet was resuspended in the appropriate concentration for each assay in the respective assay buffer.
The affinity and density of D 2 -like receptors were assessed using [ 3 H]spiperone (GE Healthcare; 96 Ci/mmol; 0.03-1.0 nM) in an equilibrium, filtration assay as previously described (Levant 2003) . The assay buffer was 50 mM Tris, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4 at 23°C. Nonspecific binding was defined in the presence of 1 mM (+)−butaclamol. Assay tubes were incubated at 23°C for 90 min. The reaction was terminated by rapid vacuum filtration. Bound radioactivity was quantified using a Beckman LS-6500 liquid scintillation counter. Membrane protein concentrations were determined by the BCA method (Pierce, Rockford, IL) and were 50 mg/tube. Specific binding is expressed as femtomole per milligram protein and analyzed for K d and B max using SigmaPlot (v. 8.0.2). D 3 receptor affinity was determined in membranes prepared from ventral striatum (nucleus accumbens and olfactory tubercle) using [ 3 H]7-OH-DPAT (GE Healthcare; 163 Ci/mmol; 0.18 nM) according to a modification of previously described methods (Bancroft et al. 1998 ). Due to the small size of the ventral striatum and the low density of D 3 sites, as well as to allow for independent determinations to be made within individual animals, binding analyses were performed using a single concentration of radioligand. Assays were performed as described above except the assay buffer was 50 mM Tris, 1 mM EDTA; pH 7.4 at 23°C, nonspecific binding was defined by 1 μM spiperone, the membrane protein concentration was 200 mg/tube, and the incubation time was 2 h.
Drugs
Cocaine was obtained from the National Institute on Drug Abuse (Bethesda, MD). Pramipexole was purchased from APAC Pharmaceutical, LLC (Columbia, MD). Physostigmine was obtained from Tocris Chemical Company (Ellisville, Mo), and TFMPP was obtained from Sigma-Aldrich (St. Louis, MO). All drugs were dissolved in physiologic saline and administered in a volume of 1.0 ml/kg. Cocaine, physostigmine, and their vehicle controls were administered i.p., whereas pramipexole, TFMPP, and their vehicle controls were administered s.c.
Data analysis
Dose-response curves for agonist-induced yawning were generated using eight saline-treated and eight cocaine-treated rats, whereas dose-response curves for pramipexole-induced ∼ ∼ locomotor activity and changes in core body temperature, as well as cocaine-induced locomotor activity, were generated using six saline-treated and six cocaine-treated rats. Binding studies were conducted on tissue from ten saline-treated, and ten cocaine-treated (five of each condition at the 24 h and 42-day time-points). All yawning data are expressed as the mean±standard error of the mean (SEM) number of yawns observed during the 30 min immediately after injection. Pramipexole-induced locomotor activity represents the mean±SEM of the total locomotor activity for the 30-min period following each injection, whereas pramipexole-induced changes in core body temperature represent the mean±SEM difference in the core body temperature as measured 30 min after each injection compared to the core body temperature measured 1 min before the saline injection. Significant main effects of treatment on agonist-induced yawning, locomotor activity, and changes in core body temperature between the cocaine-and saline-treated groups were determined by two-way, repeated-measures analysis of variance (ANOVA) with post-hoc Bonferroni tests (GraphPad Prism; GraphPad Software Inc., San Diego, CA). Significant main effects of time on agonist-induced yawning, locomotor activity, and changes in core body temperature within the cocaine-and saline-treated groups were determined by two-way, repeated-measures analysis of variance (ANOVA) with post-hoc Bonferroni tests. Significant main effects of treatment on saline-and cocaine-induced locomotor activity between the cocaineand saline-treated groups were determined by two-way, repeated-measures analysis of variance (ANOVA) with post-hoc Bonferroni tests. Two-tailed, paired t tests were used to determine significant differences between the cocaine-and saline-treated groups with respect to the total locomotor activity observed over the 60-min bins following saline and cocaine injections. Significant differences in B max and K d between the saline-and cocaine-treated groups were determined by two-tailed, paired t tests.
Results
Effects of cocaine treatment on cocaine-induced locomotor activity
As shown in Fig. 1 , the locomotor response to 15.0 mg/kg; i.p. cocaine was significantly enhanced [F(1,110)=5.38; p<0.05] in rats that were treated with cocaine as compared to saline 42 days prior to testing. In addition, although this enhancement of cocaine-induced locomotor activity was observed even when the locomotor effects of cocaine were summed over 5-min or 60-min (p<0.05) bins, there was no effect of prior cocaine treatment on locomotor response to saline.
Effects of cocaine treatment on pramipexole-induced behavioral effects As shown in Fig. 2 , a progressive increase in the amount of yawning induced by pramipexole was observed 24 h to 42 days after 7 days of cocaine administration (15 mg/kg; i.p. ×2 days and 30 mg/kg, i.p. ×5 days). Pramipexole produced significant dose-dependent increases in yawning in both the cocaine-and saline-treated groups at all experimental time-points (main effect of dose, all F> 13.18 and all p<0.001). Although there were no differences between the saline-and cocaine-treated rats with respect to pramipexole-induced yawning 24 h after the cessation of cocaine or saline treatment, significant differences in the number of yawns induced by a low dose of pramipexole (0.032 mg/kg) were observed at the 10-day (p<0.05), 21-day (p<0.001), and 42-day (p<0.001) time-points. Between group comparisons revealed a significant main effect of treatment at 21 days [F(1,70)=8.87; p<0.01] and 42 days [F(1,70)=10.38; p<0.05] after the cessation of cocaine. Within-subjects analyses revealed a significant main effect of time from treatment for the cocaine-treated group (n=6 per group) of the total locomotor activity for each 5-min bin and for each 60-min bin (inset panels) following administration of saline and cocaine. *p<0.05; **p<0.01. Significant differences in the amount of locomotor activity for cocaine-and saline-treated groups were determined by two-way, repeated-measures ANOVA with post-hoc Bonferroni tests (5-min bins) and by twotailed, paired t tests [F(4,168) =3.31; p<0.05], but not the saline-treated rats. Cocaine-treatment resulted in a progressive increase in the number of yawns induced by a low dose of pramipexole (0.032 mg/kg), with significantly greater amounts of yawning observed 72 h (p<0.01), 10 days (p<0.01), 21 days (p<0.001), and 42 days (p<0.001) after cessation of cocaine treatment as compared to the 24 h time-point; a significant decrease in number of yawns induced by 0.1 mg/kg pramipexole (p<0.05) was also observed at the 42 days compared to the 24 h time-point. With the exception of the 72 h time-point (0.1 mg/kg pramipexole; p<0.05) pramipexole-induced yawning was no different than the 24 h time-point for the saline-treated group.
As shown in Fig. 3 , there were no significant differences between the cocaine-and saline-treated groups with respect to pramipexole-induced changes in core body temperature or locomotor activity at any time after cessation of treatment. Although pramipexole induced dose-dependent decreases in core body temperature at all experimental time-points (main effect of dose, all F>11.67 and all p< 0.001), a significant effect of time from treatment was observed for both the cocaine-[F(3,90)=14.65; p<0.001] and saline-treated groups [F(3,90)=11.15; p<0.001]. Additionally, slight differences in the hypothermic effects of pramipexole were observed throughout the duration of the experiment, as compared to the respective 24 h time-points [(saline-treated, 72 h-0.32 mg/kg, p<0.01; 21 days-1.0 mg/kg, p<0.05), and (cocaine-treated, 10 days-1.0 mg/kg, p<0.05; 21 days-0.1 mg/kg, p<0.001 and 1.0 mg/kg, p<0.01)]. Unlike pramipexole-induced yawning and hypothermia, dose-dependent decreases in locomotor activity were only observed 24 h after cessation of treatment [F(5,50)= 4.19; p <0.01], and there was no significant effect of time from treatment in either the cocaine-or saline-treated groups. A dose of 1.0 mg/kg pramipexole did induce significantly more locomotor Fig. 2 Dose-response curves for pramipexole-induced yawning in cocaine-and saline-treated rats as assessed 24 h, 72 h, 10, 21, and 42 days after the cessation of repeated cocaine or saline administration. Data represent the mean±S.E.M. (n=8 per group) number of yawns observed during the 30-min period following each injection. *p<0.05; ***p<0.001. Significant effect of cocaine treatment on yawning compared to the saline-treated group at that particular timepoint as determined by two-way, repeated-measures ANOVA with post-hoc Bonferroni tests. +p<0.05. Significant difference in the amount of yawning observed for the saline-treated group compared to the 24 h saline-treated time-point as determined by two-way, repeatedmeasures ANOVA with post-hoc Bonferroni tests. ##p<0.01; ###p< 0.001. Significant difference in the amount of yawning observed for the cocaine-treated group compared to the 24 h cocaine-treated timepoint as determined by two-way, repeated-measures ANOVA with post-hoc Bonferroni tests activity in the saline-treated group at the 10-day time-point as compared to the locomotor response in the same group at the 24 h time-point.
Effects of cocaine treatment on physostigmineand TFMPP-induced behavioral effects
Although physostigmine and TFMPP produced dosedependent increases in yawning in both the cocaine-and saline-treated groups (main effect of dose: all F>3.39 and all p<0.05), treatment with cocaine did not alter the capacity of physostigmine or TFMPP to induce yawning (main effect of treatment: all F<2.8 and all p>0.12) during the 24/72 h or 41/43-day time-points (Table 1) . Moreover, a significant effect of time from treatment was only observed for TFMPP-induced yawning in the saline-treated group [F(1,28)=24.08; p<0.001); an effect that was primarily due to a significant reduction in the number of yawns induced by 3.2 mg/kg TFMPP at the 41/43-day time-point compared to the 24/72-h time-point (p<0.001).
Effects of cocaine treatment on dopamine D 2 -like and D 3 receptor binding
The effects of cocaine treatment on D 2 -like density and affinity, as determined from membranes prepared from the ventral striatum (nucleus accumbens and olfactory tubercle), are shown in Table 2 . Although there were no Fig. 3 Dose-response curves for pramipexole-induced changes in core body temperature (left panels) and locomotor activity (right panels) in cocaine-and saline-treated rats as assessed 24 h, 72 h, 10, and 21 days after the cessation of repeated cocaine or saline administration. Data represent the mean±S.E.M. (n=6 per group) change in core body temperature as measured 30 min after each injection compared to the core body temperature 1 min prior to the first injection and mean±S.E. M. (n=6 per group) locomotor activity counts summed over the 30 min following each injection. +p<0.05; ++p<0.01. Significant difference in the change in core body temperature or locomotor activity for the saline-treated group compared to the 24 h saline-treated time-point as determined by two-way, repeated-measures ANOVA with post-hoc Bonferroni tests. #p<0.05; ##p<0.01; ###p<0.001. Significant difference in the change in core body temperature or locomotor activity for the cocaine-treated group compared to the 24 h cocaine-treated time-point as determined by two-way, repeated-measures ANOVA with post-hoc Bonferroni tests significant effects of treatment on D 2 -like density or affinity at the 24 h time-point, significant differences were observed 42 days after cessation of cocaine/saline treatment. Not only did cocaine treatment result in a significant decrease in the density of ventral striatal D 2 -like receptors compared to the 24 h cocaine-treated group (p<0.05), but cocaine treatment also resulted in a decrease in ventral striatal D 2 -like receptor density as compared to the saline-treated group at the 42-day time-point (p<0.05). In addition to the effects of cocaine treatment on D 2 -like receptor density, ventral striatal samples taken from the cocaine-treated rats at the 42-day time-point also showed a significant increase in D 2 -like receptor affinity as compared to the 42-day salinetreated group (p<0.001). Although it was possible to assess changes to both D 2 -like receptor density and affinity, the relatively low levels of expression and limited amount of ventral striatal samples precluded similar analyses with regard to D 3 receptors; however, as shown in Fig. 4 , there was a significant effect of cocaine treatment on D 3 receptor binding as determined by a single-point binding assay. Although D 3 receptor binding within the ventral striatum did not differ between the saline-and cocaine-treated groups at the 24 h time-point, cocaine treatment did result in a significant increase in D 3 receptor binding at the 42-day time-point.
Discussion
In agreement with the majority of previous studies, cocainetreated rats displayed an enhanced locomotor response to cocaine 42 days after the cessation of cocaine, suggesting that the current regimen of cocaine administration was sufficient to produce a long-lasting behavioral sensitization to cocaine. In addition, although cocaine treatment failed to alter pramipexole-induced locomotor activity or hypothermia, cocaine-treated rats displayed a progressive and persistent leftward and/or upward shift in the ascending limb of the dose-response curve for pramipexole-induced yawning, as well as a leftward shift in the inhibition of yawning that comprises the descending limb of the doseresponse curve for yawning. The temporal differences in the development of these two effects suggest that increases in the sensitivity of rats to D 3 -mediated behavioral effects become apparent shortly after the cessation of cocaine with progressive and persistent enhancements observed for up to 42 days, whereas increases in the sensitivity of rats to D 2 -after the cessation of cocaine.
Although it has been well established that repeated, experimenter-or self-administered cocaine results in a .05. Significant effect of cocaine treatment on Bmax compared to the saline-treated group at the 42-day time-point as determined by twotailed, paired t tests. **p<0.05; ***p<0.001. Significant difference in B max or K d for the cocaine-treated group at the 42-day time-point compared to the cocaine-treated group at the 24 h time-point as determined by two-tailed, paired t tests mediated behavioral effects do not emerge until ∼42 days progressive and persistent enhancement of the locomotor stimulatory effects of subsequent cocaine challenges (Heidbreder et al. 1996; Henry and White 1995; Kalivas and Duffy 1993) , it is important to note that crosssensitization between the locomotor stimulatory effects of cocaine and direct D 2 -like agonists has been reported with self-administered cocaine (De Vries et al. 2002; Dias et al. 2004; Edwards et al. 2007 ), but not experimenteradministered cocaine (e.g., Djano and Martin-Iverson 2000) . The inability of cocaine to cross-sensitize rats to the locomotor stimulatory effects of pramipexole in the present studies provides further support for this dichotomy between experimenter-and self-administered cocaine. However, it is possible that cross-sensitization was not observed due to the relatively low doses of pramipexole that were used, the relatively short period of time that pramipexole-induced locomotor activity was measured, or some combination thereof (De Vries et al. 2002; Dias et al. 2004; Edwards et al. 2007 ). Alternatively, it has also been suggested that the development (Henry et al. 1998; Hoffman and Wise 1993) and expression (Djano and Martin-Iverson 2000; Kiyatkin 1994 ) of cross-sensitization between the locomotor stimulatory effects of experimenter-administered cocaine and D 2 -like agonists depends upon an activation of both D 1 -and D 2 -like receptors, raising the possibility that basal extracellular dopamine levels were insufficient to activate D 1 -like receptors during the locomotor tests. Nevertheless, when taken together with previous reports of food restrictioninduced enhancements of the locomotor stimulatory effects of pramipexole under identical experimental conditions (Collins et al. 2008) , the current findings suggest that locomotor assays are insufficient to detect changes in D 2 and/or D 3 receptor sensitivity following experimenteradministered cocaine in rats. Despite this inability of prior cocaine administrations to alter the locomotor effects of pramipexole, cocaine-treated rats displayed a progressive and persistent leftward and upward shift of the D 3 -mediated (Collins et al. 2007; Collins et al. 2005) , ascending limb of the dose-response curve for pramipexole-induced yawning, as well as an increased sensitivity to the D 2 -mediated (Collins et al. 2007; Collins et al. 2005 ) inhibitory effects of pramipexole on yawning when tested after the cessation of cocaine administration. These findings not only suggest that yawning assays are sensitive enough to differentiate between cocaine-induced changes in the D 3 -and D 2 -mediated behavioral effects of pramipexole, but also that there are temporal differences in these effects. Progressive enhancements of D 3 -mediated behaviors emerged shortly after the cessation of cocaine administration ( 72 h) and persisted for at least 42 days, whereas increases in the sensitivity of rats to some D 2 -mediated behaviors do not become apparent until after a prolonged period of time since the cessation of cocaine administration ( 42 days). Importantly, cocaine treatment failed to alter the induction of yawning by the indirect cholinergic agonist, physostigmine, or the 5-HT2 receptor agonist, TFMPP, suggesting that the cocaine-induced changes in pramipexole-induced yawning represent changes in the sensitivity and/or expression of the D 3 and D 2 receptors that mediate yawning and not a more general enhancement of the signaling pathways within the paraventricular nucleus that regulate yawning.
Although the relatively low levels of D 2 and D 3 receptor expression and small volume of the paraventricular nucleus precluded the ability to accurately assess changes in the binding properties of D 2 -like receptors within this brain region, the results of radioligand binding studies performed on ventral striatal tissue provide molecular evidence to support these behavioral changes. Importantly, although 3 H-spiperone binds to both the D 2 and D 3 receptor subtypes, its preferential affinity for D 2 compared to D 3 receptor ( 80-fold selective for D 2 over D 3 in rat brain using the current in vitro assay conditions; Levant and DeSouza 1993) , combined with the differential levels of expression for the D 2 and D 3 receptors (D 2 expressed means that the cocaine-induced changes in the B max and K d obtained with 3 H-spiperone in the current studies can be primarily attributed to changes in the binding properties of D 2 receptors. Similar to what was observed with pramipexole-induced yawning at the 24 h time-point, cocaine treatment failed to alter the binding properties of D 3 or D 2 -like receptors at this early time-point. Although previous studies in mice, rats, and rhesus monkeys have suggested that cocaine is capable of altering D 2 -like receptor levels within a few hours of the last cocaine administration (Bailey et al. 2008; Le Foll et al. 2005; Maggos et al. 1998; Nader et al. 2002; Nader et al. 2006; Tsukada et al. 1996) , it is important to note that differences at ∼100-fold higher levels than D 3 ; Levesque et al. 1992) , in the dosing regimen, route of administration, and length of time since cocaine treatment are all known to affect changes in D 2 -like receptor density (e.g., Anderson and Pierce 2005) . Consistent with the cocaine-induced changes in pramipexole-induced yawning that developed over the course of the study, significant increases in D 3 receptor binding, as well as significant decreases in D 2 -like receptor density and increases in D 2 -like receptor affinity were observed in the ventral striatum of cocaine-treated rats 42 days after the cessation of cocaine. Not only are these cocaine-induced changes in D 3 receptor binding similar to the time-dependent increases in D 3 receptor binding and cell surface expression that have been reported following periods of cocaine self-administration in rats (Conrad et al. 2010; Neisewander et al. 2004 ), but the observed decreases in D 2 -like receptor density are also similar to recent reports of decreases in D 2 receptor expression in rats with a history of cocaine self-administration (Conrad et al. 2010) . It should be noted, however, that similar decreases in D 2 and increases in D 3 receptor densities have also been reported following the repeated administration of high doses of D 2 -like agonists (Stanwood et al. 2000) . Although an interaction between cocaine pretreatment and pramipexole cannot be ruled out, the fact that repeated pramipexole administration failed to alter the binding properties of either D 2 -like or D 3 receptors in the saline-treated group suggests that the observed changes in D 2 -like and D 3 receptor binding resulted from the repeated administration of cocaine, and not pramipexole.
Curiously, unlike the rapid sensitization of rats to the D 2 -mediated effects of pramipexole that has been observed with food restriction (Collins et al. 2008) , cocaine treatment appeared to have a delayed effect on the D 2 -mediated effects of pramipexole as no changes in the sensitivity of rats to the inhibition of yawning, induction of hypothermia, and locomotor stimulation were observed throughout the first 21 days after the cessation of cocaine administration. Importantly, however, increases in the sensitivity of rats to the inhibitory effects of pramipexole on yawning corresponded to a significant decrease in K d for [ 3H ]-spiperone at D 2 -like receptors at 42 days, suggesting that the observed behavioral changes were mediated by an increased affinity of pramipexole at the D 2 receptor. Although the current studies were not designed to differentiate between the highand low-affinity states of D 2 receptors, it is possible that the increased sensitivity of the cocaine-treated rats to the D 2 -mediated inhibition of pramipexole-induced yawning was also influenced by an increased proportion of D 2 receptors in the high-affinity state as has been reported in rats following cocaine self-administration (Briand et al. 2008) or sensitization to caffeine (Simola et al. 2008) or amphetamine (Seeman 2009 ). In addition to providing convergent evidence to support a cocaine-induced sensitization of the D 2 receptor, the current studies also suggest that increases in D 3 receptor binding may underlie the progressive increase in the sensitivity of cocaine-treated rats to the D 3 -mediated induction of yawning by low doses of pramipexole. However, the limitations of single-point assays make it impossible to determine whether these behavioral changes resulted from an increase in D 3 receptor density, D 3 receptor affinity, or some combination of the two. Interestingly, Hamilton et al. (2010) have recently reported a similar enhancement of D 2 -like agonist-induced yawning in male monkeys that were exposed to cocaine in utero. Not only was this effect positively correlated with the maximal daily dose of cocaine received during gestation, but this enhanced yawning response was observed 13 years later, suggesting that cocaine exposure may result in long lasting, if not permanent enhancements of the function and/or sensitivity of D 3 receptors.
In addition to altering the potency and/or effectiveness of drugs (e.g., psychostimulants or D 2 -like agonists) to stimulate locomotor activity or elicit other behavioral effects, the neuroadaptations that underlie behavioral sensitization are also thought to play a crucial role in the development of addiction-like behaviors in animals (e.g., Kalivas and Stewart 1991; Robinson and Berridge 1993; Vezina 2004) , such as the increased capacity of cocaine and direct D 2 -like agonists to increase responding that was previously reinforced by cocaine (De Vries et al. 1998; De Vries et al. 2002; Dias et al. 2004; Edwards et al. 2007) . Although these studies suggest that increases in responding are mediated by a sensitization of D 2 -like receptors in general, there is growing evidence to support a role for the D 3 receptor, specifically in the capacity of cocaine-paired cues to reinstate or maintain responding following periods of cocaine self-administration (Cervo et al. 2007; Gal and Gyertyan 2006; Gilbert et al. 2005) . Given this putative role for the D 3 receptor, it is interesting to note that the capacity of these cues to reinstate responding appears to be positively correlated with the duration of abstinence insofar as progressive and persistent increases in responding have been observed over the first 3 months of abstinence (e.g., Grimm et al. 2001; Lu et al. 2004) . This effect appears to be similar in magnitude and time course to the increases in D 3 -mediated yawning observed in the current studies.
In summary, these studies provide convergent behavioral and molecular evidence to support a cocaine-induced enhancement of both D 3 -and D 2 -mediated elicited behavioral effects in rats. The temporal differences in the development of these effects suggest that increases in the sensitivity of rats to the D 3 -mediated effects of pramipexole emerge as early as 72 h after the cessation of cocaine administration with progressive and persistent enhancements observed for at least 42 days, whereas increases in the sensitivity of rats to the D 2 -mediated behavioral effects of pramipexole do not become apparent until after longer periods of time have passed. In addition to suggesting that D 2 -like agonist-induced yawning may provide a valuable tool for the evaluation of the functional changes in D 3 and D 2 receptors that occur following cocaine administration, when taken together with previous reports (Conrad et al. 2010; Hamilton et al. 2010; Neisewander et al. 2004 ), these studies provide further support for the notion that the progressive and persistent increases in the density, function, and/or sensitivity of the D 3 receptor that occur during periods of abstinence or withdrawal may contribute to the enduring vulnerability to relapse commonly observed in human drug abusers.
